Several studies indicate that natural killer T (NKT) cells display detrimental effects during NASH development, and this cells can be activated in response to elevated levels of IL-12, type I interferons and IL-1 during NASH [173]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.